Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.18 USD | +0.32% | -0.64% | +22.38% |
15/05 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
09/05 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.38% | 76Cr | |
+11.60% | 11TCr | |
-4.68% | 2.43TCr | |
-0.61% | 2.2TCr | |
-9.33% | 1.82TCr | |
-42.12% | 1.64TCr | |
-17.47% | 1.56TCr | |
+2.77% | 1.36TCr | |
+34.58% | 1.23TCr | |
+77.64% | 887.31Cr |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Earnings Flash (WVE) WAVE LIFE SCIENCES USA Reports Q1 Revenue $12.9M, vs. Street Est of $38.6M